Ipsen in the Americas: Somatuline and Sativex

Save

Firstly, it has decided to go it alone in commercializing its Somatuline Depot (lanreotide) injection treatment for neuroendocrine tumors (NETs) in the US, after weighing up the possibility of seeking a partner for this market.